Pricing Log in Create free account
Friday 6 November 2026 Export VTRS’s income statement to Excel — free account

Viatris Inc.

VTRS Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024.

Revenue
−0.28%
EPS
−154.6%
Free cash flow
+38.8%
Total debt
−89.4%

Quarter to September 2026, against a year earlier

18.89 0.33 −1.72%
Market cap
$21.8B
P/E
0.0×
Fwd P/E
82.6×
Dividend yield
2.54%
F-score
4/9
Altman Z
0.61
Beneish M
−3.29
Dividend safety
37/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

Viatris Inc. (VTRS) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Viatris Inc. (VTRS) trades at a price to free cash flow of 10.7×. Over the past ten years it has ranged from 2.1× (April 2025) to 135× (July 2015); the current reading is higher than 55% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 16.3× and below the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 7.5× 125.96%
FY2024 3.3× (31.78%)
FY2023 4.9× (9.15%)
FY2022 5.4× (17.11%)
FY2021 6.5× (68.23%)
FY2020 20.4× 180.37%
FY2019 7.3× (39.38%)
FY2018 12.0× (34.66%)
FY2017 18.4× 18.63%
FY2016 15.5× (30.96%)

Quarterly newest first

Period Price to free cash flow Change
Sep 2026 10.0× 2.65%
Jun 2026 9.8× 7.77%
Mar 2026 9.1× 20.62%
Dec 2025 7.5× 6.77%
43 more quarters

Against its own ten years

Low 2.1× High 135×
Ten-year median 9.3×
Current reading's percentile 55

Price to free cash flow against peers

Company Price to free cash flow
HLN Haleon PLC Sponsored ADR compare 9.2×
VTRS Viatris Inc. 10.7×
ZTS Zoetis Inc. compare 14.7×
NBIX Neurocrine Biosciences, Inc. compare 15.7×
UTHR United Therapeutics Corporation compare 28.0×
ALKS Alkermes plc compare 32.8×
ELAN Elanco Animal Health Incorporated compare 33.2×
TEVA Teva Pharmaceutical Industries Ltd. compare 36.6×
RDY Dr. Reddy's Laboratories Ltd compare 126×
Drug Manufacturers Specialty & Generic industry median 16.3×
Healthcare sector median 21.1×
Market median 14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on VTRS